| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $171K | +14.6% | -1.6% |
| SG&A Expense | $453K | -2.4% | -8.5% |
| Operating Income | -$624K | -1.8% | +6.7% |
| Net Income | -$589K | -3.3% | +9.9% |
| EPS (Basic) | -$0.01 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% | +0.0% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.4M | -8.6% | +42.0% |
| Current Assets | $5.5M | -9.1% | +40.0% |
| Total Assets | $5.6M | -9.1% | +41.3% |
| Current Liabilities | $278K | +13.8% | -22.1% |
| Total Liabilities | $278K | +13.8% | -22.1% |
| Stockholders' Equity | $5.3M |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | -80.6% | — |
| Investing Cash Flow | -$30K | +0.0% | — |
| +47.6% |